Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00838006Not ApplicableCompleted

Psychophysiologic Predictors of Post-deployment Mental Health Outcomes

Role: lead

NCT02962505Completed

Continuous Regional Analysis Device for Neonate Lung

Role: collaborator

NCT01726088Phase 2Unknown

Modafinil in the Treatment of PTSD (Posttraumatic Stress Disorder)

Role: lead

All 3 trials loaded